Aarti Pharmalabs shows strong potential for future growth after delivering robust financial results in March quarter, according to analyst Varunkumar Patel. Current profitability growth, along with stable demand in core segments, suggest positive developments ahead for pharmaceutical manufacturing and CDMO services.